Louise Carlson
Immunology and Microbiology · Indiana University
Publications
124
Citations
7,071
Est. group size
—
Recurring co-author estimate
Active years
54
Publishing since 1972
Louise Carlson studies how immune cells—especially antibody-producing plasma cells and cancerous plasma cells in multiple myeloma—survive and stay functional. The work examines the molecular signals (such as CD28 signaling, the enzyme IDO, and cellular recycling processes called autophagy) that keep these cells alive, and explores how this knowledge can be turned into treatments for blood cancers. Recent projects include clinical trials and drug strategies aimed at improving myeloma therapy.
Publication activity has been steady through the late 2010s and has grown noticeably in the most recent years (5 in 2024 and 6 in 2025).
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Typically publishes in teams of ~7 · 21% small-team papers (≤3 authors) · across 9 venues
- Pro-survival signaling regulates lipophagy essential for multiple myeloma resistance to stress-induced death
Cell Reports · 2024
- Phase 2 study of abatacept, ixazomib, and dexamethasone in patients with relapsed/refractory multiple myeloma.
Journal of Clinical Oncology · 2023
- Systems Pharmacology Modeling Identifies a Novel Treatment Strategy for Bortezomib-Induced Neuropathic Pain
Frontiers in Pharmacology · 2022
- Mitigating the prevalence and function of myeloid-derived suppressor cells by redirecting myeloid differentiation using a novel immune modulator
Journal for ImmunoTherapy of Cancer · 2022
- Indoleamine 2,3-dioxygenase 1 is essential for sustaining durable antibody responses
Immunity · 2021
- Indoleamine 2,3-Dioxygenase 1 is Essential for Sustaining Durable Antibody Responses
SSRN Electronic Journal · 2020
- CD28 Induces Autophagy in Plasma Cells to Enhance Mitochondrial Respiration and Survival
The Journal of Immunology · 2020
- A novel role for indoleamine 2,3-dioxygenase (IDO) in supporting the survival of long lived plasma cells (LLPC)
The Journal of Immunology · 2020
- The surprising role of Indoleamine 2,3-dioxygenase (IDO) in supporting the survival of bone marrow resident long lived plasma cells (LLPC)
The Journal of Immunology · 2019
- CD28 Regulates Autophagy to Enhance Plasma Cells Survival
The Journal of Immunology · 2019
- The role of Indoleamine 2,3-dioxygenase (IDO) in the survival of bone marrow resident long lived Plasma cells
The Journal of Immunology · 2018
- CD28 Induces Mitochondrial Respiration Dependent Reactive Oxygen Species (ROS) Signaling for Metabolic Fitness and Survival in Long-Lived Plasma Cells
The Journal of Immunology · 2018
- CD28 induces survival in long-lived plasma cells through NFκB mediated Irf4 upregulation and mitochondrial respiration-dependent reactive oxygen species production.
The Journal of Immunology · 2017
- The role of Indoleamine 2,3-dioxygenase (IDO) in the survival of bone marrow resident long lived Plasma cells
The Journal of Immunology · 2017
- CD28 Induces Mitochondrial Respiration through Irf4 for Long Lived Plasma Cells Survival
Blood · 2016
- The Journal of Immunology×12
- Blood×5
- Clinical Lymphoma Myeloma & Leukemia×5
- Cell Reports×1
- Immunity×1
- Wei Luo
Immunology and Microbiology · Indiana University
- Harm HogenEsch
Immunology and Microbiology · Purdue University West Lafayette
- Soo Ngoi
Immunology and Microbiology · The Ohio State University
- Fang Ke
Immunology and Microbiology · University of Michigan
- Prasida Holla
Immunology and Microbiology · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile